ABBOTT LABORATORIES (ABT) Stock Earnings & Estimates
USA - NYSE:ABT - US0028241000 - Common Stock
123.62 USD
-1.05 (-0.84%)
123.97 USD
+0.35 (+0.28%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 43.653B 1.34% | 40.109B -8.12% | 41.95B 4.59% | 45.12B 7.56% | 48.63B 7.78% | 52.27B 7.49% | 55.644B 6.45% | 59.809B 7.49% | 65.756B 9.94% | |
| EBITDA YoY % growth | 11.974B -1.25% | 9.965B -16.78% | 10.211B 2.47% | 12.027B 17.78% | 13.231B 10.01% | 14.556B 10.01% | 15.531B 6.70% | 16.8B 8.17% | N/A | |
| EBIT YoY % growth | 8.707B 1.39% | 6.722B -22.80% | 6.993B 4.03% | 10.532B 50.61% | 11.722B 11.30% | 12.946B 10.44% | 14.199B 9.68% | 15.846B 11.60% | 16.985B 7.19% | |
| Operating Margin | 19.95% | 16.76% | 16.67% | 23.34% | 24.10% | 24.77% | 25.52% | 26.49% | 25.83% | |
| EPS YoY % growth | 5.34 2.50% | 4.44 -16.85% | 4.67 5.18% | 5.20 11.44% | 5.74 10.25% | 6.36 10.86% | 6.93 8.93% | 7.48 7.93% | 8.32 11.29% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.51 12.85% | 1.22 11.71% | 1.41 12.08% | 1.47 12.78% | 1.60 5.81% | 1.47 21.10% | 1.65 16.57% | 1.61 9.53% | 1.68 4.79% |
| Revenue Q2Q % growth | 11.919B 8.61% | 11.344B 9.52% | 12.149B 9.04% | 12.434B 9.37% | 12.811B 7.48% | 12.284B 8.29% | 13.429B 10.54% | 13.295B 6.92% | 13.612B 6.25% |
| EBITDA Q2Q % growth | 3.456B -33.69% | 2.854B 14.94% | 3.272B -10.48% | 3.437B 12.43% | 3.706B 7.23% | 3.435B 20.36% | 3.761B 14.94% | 3.717B 8.15% | 3.857B 4.07% |
| EBIT Q2Q % growth | 3.075B 54.21% | 2.47B 43.02% | 2.895B 36.43% | 3.013B 38.34% | 3.311B 7.67% | 3.034B 22.83% | 3.331B 15.06% | 3.297B 9.43% | 3.417B 3.20% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.30 7.44% | 1.31 | -0.01 | -1.06% |
| Q2 2025 Q2Q % growth | 1.26 10.53% | 1.27 | -0.01 | -0.58% |
| Q1 2025 Q2Q % growth | 1.09 11.22% | 1.08 | 0.01 | 0.73% |
| Q4 2024 Q2Q % growth | 1.34 12.61% | 1.36 | -0.02 | -1.16% |
| Q3 2024 Q2Q % growth | 1.21 6.14% | 1.21 | 0.00 | -0.34% |
| Q2 2024 Q2Q % growth | 1.14 5.56% | 1.12 | 0.02 | 2.22% |
| Q1 2024 Q2Q % growth | 0.98 -4.85% | 0.96 | 0.02 | 1.61% |
| Q4 2023 Q2Q % growth | 1.19 15.53% | 1.20 | -0.01 | -0.89% |
| Q3 2023 Q2Q % growth | 1.14 -0.87% | 1.11 | 0.03 | 2.82% |
| Q2 2023 Q2Q % growth | 1.08 -24.48% | 1.06 | 0.02 | 1.87% |
| Q1 2023 Q2Q % growth | 1.03 -40.46% | 1.00 | 0.03 | 3.24% |
| Q4 2022 Q2Q % growth | 1.03 -21.97% | 0.93 | 0.10 | 11.12% |
| Q3 2022 Q2Q % growth | 1.15 -17.86% | 0.95 | 0.20 | 20.60% |
| Q2 2022 Q2Q % growth | 1.43 22.22% | 1.14 | 0.29 | 25.59% |
| Q1 2022 Q2Q % growth | 1.73 31.06% | 1.48 | 0.25 | 16.92% |
| Q4 2021 Q2Q % growth | 1.32 -8.97% | 1.22 | 0.10 | 8.36% |
| Q3 2021 Q2Q % growth | 1.40 42.86% | 0.95 | 0.45 | 46.65% |
| Q2 2021 Q2Q % growth | 1.17 105.26% | 1.03 | 0.14 | 13.83% |
| Q1 2021 Q2Q % growth | 1.32 103.08% | 1.29 | 0.03 | 2.59% |
| Q4 2020 Q2Q % growth | 1.45 52.63% | 1.37 | 0.08 | 6.14% |
| Q3 2020 Q2Q % growth | 0.98 16.67% | 0.92 | 0.06 | 6.89% |
| Q2 2020 Q2Q % growth | 0.57 -30.49% | 0.43 | 0.14 | 33.23% |
| Q1 2020 Q2Q % growth | 0.65 3.17% | 0.59 | 0.06 | 10.56% |
| Q4 2019 Q2Q % growth | 0.95 | 0.96 | -0.01 | -0.57% |
| Q3 2019 Q2Q % growth | 0.84 | 0.85 | -0.01 | -1.15% |
| Q2 2019 Q2Q % growth | 0.82 | 0.81 | 0.01 | 1.21% |
| Q1 2019 Q2Q % growth | 0.63 | 0.62 | 0.01 | 1.81% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 11.369B 6.90% | 11.518B | -149M | -1.29% |
| Q2 2025 Q2Q % growth | 11.142B 7.37% | 11.179B | -37M | -0.33% |
| Q1 2025 Q2Q % growth | 10.358B 3.95% | 10.502B | -144M | -1.37% |
| Q4 2024 Q2Q % growth | 10.974B 7.16% | 11.122B | -148M | -1.33% |
| Q3 2024 Q2Q % growth | 10.635B 4.85% | 10.655B | -20M | -0.19% |
| Q2 2024 Q2Q % growth | 10.377B 4.00% | 10.474B | -97M | -0.93% |
| Q1 2024 Q2Q % growth | 9.964B 2.23% | 9.979B | -15M | -0.15% |
| Q4 2023 Q2Q % growth | 10.241B 1.49% | 10.282B | -41M | -0.40% |
| Q3 2023 Q2Q % growth | 10.143B -2.56% | 9.904B | 239M | 2.41% |
| Q2 2023 Q2Q % growth | 9.978B -11.36% | 9.795B | 183M | 1.87% |
| Q1 2023 Q2Q % growth | 9.747B -18.06% | 9.733B | 14M | 0.14% |
| Q4 2022 Q2Q % growth | 10.091B -12.01% | 9.762B | 329M | 3.37% |
| Q3 2022 Q2Q % growth | 10.41B -4.74% | 9.777B | 633M | 6.47% |
| Q2 2022 Q2Q % growth | 11.257B 10.11% | 10.422B | 835M | 8.01% |
| Q1 2022 Q2Q % growth | 11.895B 13.76% | 11.097B | 798M | 7.19% |
| Q4 2021 Q2Q % growth | 11.468B 7.17% | 10.815B | 653M | 6.04% |
| Q3 2021 Q2Q % growth | 10.928B 23.44% | 9.655B | 1.273B | 13.18% |
| Q2 2021 Q2Q % growth | 10.223B 39.51% | 9.787B | 436M | 4.45% |
| Q1 2021 Q2Q % growth | 10.456B 35.34% | 10.793B | -337M | -3.12% |
| Q4 2020 Q2Q % growth | 10.701B 28.71% | 10.035B | 666M | 6.64% |
| Q3 2020 Q2Q % growth | 8.853B 9.62% | 8.624B | 229M | 2.66% |
| Q2 2020 Q2Q % growth | 7.328B -8.16% | 6.875B | 453M | 6.59% |
| Q1 2020 Q2Q % growth | 7.726B 2.53% | 7.415B | 311M | 4.19% |
| Q4 2019 Q2Q % growth | 8.314B | 8.346B | -32M | -0.38% |
| Q3 2019 Q2Q % growth | 8.076B | 8.185B | -109M | -1.33% |
| Q2 2019 Q2Q % growth | 7.979B | 8.076B | -97M | -1.20% |
| Q1 2019 Q2Q % growth | 7.535B | 7.549B | -14M | -0.19% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.03% | 0.1% | 0.15% | -0.15% |
| Revenue | -0.02% | -0.02% | -0.05% | 0% |